LENZ Therapeutics Inc. (LENZ)
NASDAQ: LENZ
· Real-Time Price · USD
41.04
0.51 (1.26%)
At close: Sep 24, 2025, 3:59 PM
40.50
-1.32%
Pre-market: Sep 25, 2025, 08:01 AM EDT
1.26% (1D)
| Bid | 40.22 |
| Market Cap | 1.17B |
| Revenue (ttm) | 5.07M |
| Net Income (ttm) | -52.4M |
| EPS (ttm) | -1.63 |
| PE Ratio (ttm) | -25.18 |
| Forward PE | -15.96 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 41.5 |
| Volume | 166,714 |
| Avg. Volume (20D) | 483,706 |
| Open | 40.74 |
| Previous Close | 40.53 |
| Day's Range | 40.10 - 41.39 |
| 52-Week Range | 16.54 - 44.00 |
| Beta | 0.45 |
| Ex-Dividend Date | n/a |
About LENZ
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LENZ
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LENZ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsLENZ Therapeutics Inc. is scheduled to release its earnings on
Nov 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
11 months ago
+5.48%
LENZ Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
11 months ago
-2.86%
LENZ Therapeutics shares are trading higher after the company announced the FDA accepted its new drug application for LNZ100 for the treatment of Presbyopia.
